Sarah Tavukcuoglu

Investor @Ziwig Biotech

Paris, FR
MOBILE NUMBERS
+91 *********19

Signup · Get unlimited contacts

WORK HISTORY

Jan 2024 — Present

Investor @Ziwig Biotech

View department →

As a shareholder in Ziwig, I’m proud to be part of a groundbreaking French biotech company revolutionizing women’s health diagnostics. Ziwig’s innovative approach combines salivary RNA analysis with AI to develop highly accurate, non-invasive diagnostic tools. Their flagship product, Ziwig Endotest®, offers a game-changing solution for endometriosis diagnosis. Ziwig’s commitment to transforming women’s healthcare through cutting-edge molecular biology and AI technology positions it at the forefront of medical innovation.#IA #Biotech #WomensHealth #HealthInnovation #FemTech

EDUCATION

2008 — 2012

EBS Paris - European Business School

Master's degree, Luxury Brand & Marketing Management

2011

Shanghai University

Bachelor’s Degree

2021 — 2024

Ecole des Plantes de Paris

Botanique et Plantes Medicinales, Herbalism/Botany

2010

Universidad Complutense de Madrid

Bachelor’s Degree

ABOUT SARAH TAVUKCUOGLU

Co-Founder + CEO @ HIPPIE DUST | Nutraceuticals & Nutricosmetics

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.

Sarah Tavukcuoglu — Investor at Ziwig Biotech in Paris, FR | Unifers